Lipidomic analyses reveal the dysregulation of oxidized fatty acids (OxFAs) and acyl-carnitines (CARs) in major depressive disorder: a case-control study
Authors:
Open Access
- 1 August 2025
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-10
Abstract
Background: Growing data indicated that individuals diagnosed with major depressive disorder (MDD) had widespread inflammation, oxidative stress, and metabolic dysregulation. The objective of our study was to detect alterations in lipids of individuals with MDD, with the ultimate aim of developing potential biomarkers that may contribute to the diagnosis and treatment of MDD. Methods: The current study was a single-center cross-sectional case-control design. Serum samples were obtained from 107 individuals diagnosed with MDD and 97 healthy controls (HC) aged 18 to 60 years. Lipidomics analysis was performed using an Ultimate 3000 UHPLC system coupled with a Q-Exactive HF MS platform. All data were processed using the specialized online software Metaboanalyst 5.0. Results: Based on the filtering criteria of false discovery rate (FDR) -adjusted P < 0.05, variable importance in projection (VIP) > 1.5, and fold change (FC) > 2.0 or < 0.5, a total of 40 lipids were identified as significantly different. In patients with MDD, we observed an increase in 11 types of oxidized fatty acids (OxFAs) and a decrease in 5 types of OxFAs. Additionally, we found that 8 types of acyl-carnitines (CARs) decreased, primarily comprising singular carbon chain structures, while 3 types of CARs increased, all with numerical carbon chain patterns. Lipid profiles yield a high area under the receiver operating characteristic (ROC) curve for differentiating MDD, with the most prominent ROC ranking being mostly attributed to OxFAs. Conclusions: Our research found significant variations in lipid levels, specifically increased OxFAs and decreased CARs, in individuals with MDD compared to HCs. Supplementation with PUFAs and acyl-carnitines warrants further investigation as a potential strategy for the management of MDD. Nevertheless, further investigation is necessary, and exercise prudence is required when examining and implementing their forms and proportions.Keywords
Funding Information
- National Natural Science Foundation of China (32300926)
This publication has 51 references indexed in Scilit:
- Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical researchJournal of Mass Spectrometry and Advances in the Clinical Lab, 2023
- Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar DisorderJAMA Psychiatry, 2023
- High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritisClinical Rheumatology, 2017
- The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease riskEuropean Psychiatry, 2017
- Ceramides and depression: A systematic reviewJournal of Affective Disorders, 2017
- Epigenetic Treatment of Neuropsychiatric Disorders: Autism and SchizophreniaDrug Development Research, 2016
- Effect of Allium macrostemon on a rat model of depression studied by using plasma lipid and acylcarnitine profiles from liquid chromatography/mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2014
- Functional lipidomics of oxidized products from polyunsaturated fatty acidsChemistry and Physics of Lipids, 2011
- A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with DepressionBiological Psychiatry, 2010
- The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosisMolecular Nutrition & Food Research, 2005